AMRXAmneal Pharmaceuticals, Inc.
12.42USDMkt Cap: 3.96B USDP/E: 33.57Last update: 2026-05-21

Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products in the United States, I…

loading…
Indicators:|

Key Statistics

Company
Market Cap3.96B USD
Enterprise Value6.54B USD
Revenue (TTM)3.05B USD
Gross Profit1.11B USD
Net Income (TTM)72.06M USD
Revenue/Share9.681 USD
Last Price12.42 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees8.7K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS03168L1052
Valuation
P/E (Trailing)33.57
P/E (Forward)10.74
PEG
EV/EBITDA9.80
EV/Revenue2.15
P/S1.30
P/B-87.46
EPS (TTM)0.37
EPS (Forward)1.16
52W Range
11.9594% of range12.45
52W High12.45 USD
52W Low11.95 USD
Profitability
Gross Margin36.88%
Oper. Margin19.57%
EBITDA Margin21.92%
Profit Margin2.39%
ROE-101.78%
ROA1.96%
Growth
Revenue Growth3.90%
Earnings Growth384.60%
Cash Flow & Leverage
Operating CF339.99M USD
CapEx (TTM)114.36M USD
FCF Margin3.33%
FCF Yield2.56%
Net Debt2.50B USD
Net Debt/EBITDA3.74
Balance Sheet
Debt/Equity-37.98
Current Ratio2.47
Quick Ratio1.51
Book Value/Sh-0.1420 USD
Cash/Share0.6290 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)17.20 USD
Target Range16.00 USD19.00 USD
# Analysts5
Ownership
Shares Out.319.02M
Float178.41M
Insiders44.12%
Institutions52.13%
Short Interest
Short Ratio7.3d
Short % Float5.55%
Short % Out.3.61%
Shares Short11.51M
Short (prev mo.)7.19M
Technical
SMA 5012.58 (-1.2%)
SMA 20011.91 (+4.3%)
Beta1.32
S&P 52W Chg28.31%
Avg Vol (30d)1.60M
Avg Vol (10d)1.51M
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)